Brief: NanoViricides Has Received Favorable FDA Comments On Its Pre-IND Application For The Lead Drug Candidate

NanoViricides,

03/06/2019 13:03

June 3 (Reuters) - NanoViricides Inc  NNVC.A :
    * NANOVIRICIDES HAS RECEIVED FAVORABLE FDA COMMENTS ON ITS
PRE-IND
APPLICATION FOR THE LEAD DRUG CANDIDATE
    * NANOVIRICIDES - U.S. FDA GENERALLY AGREED IN ITS PRE-IND
RESPONSE THAT PLAN OF DRUG DEVELOPMENT PRESENTED BY CO TO FDA IS
GENERALLY ADEQUATE AT THIS TIME
    * NANOVIRICIDES INC - U.S. FDA HAS AGREED THAT COMPANY'S
STRATEGY
FOR DRUG SUBSTANCE AND DRUG PRODUCT ACCEPTANCE CRITERIA IS
ADEQUATE
    * NANOVIRICIDES INC - ADDITIONAL NON-CLINICAL STUDIES
RECOMMENDED
BY AGENCY ARE GENERALLY CONSISTENT WITH CO'S PLANNED
IND-ENABLING NON-CLINICAL STUDIES
    * NANOVIRICIDES - PROCEEDING WITH COMPLETING IND-ENABLING
STUDIES,
WORKING TO ENGAGE APPROPRIATE CLINICAL STUDY SITES & DEVELOPING
CONCRETE CLINICAL STUDY PLANS

Source text for Eikon:  ID:nPn5MhHrJa 
Further company coverage:  NNVC.A 

 ((Reuters.Briefs@thomsonreuters.com;))